Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Human immunodeficiency virus type 1 Nef induces programmed death 1 expression through a p38 mitogen-activated protein kinase-dependent mechanism.

Muthumani K, Choo AY, Shedlock DJ, Laddy DJ, Sundaram SG, Hirao L, Wu L, Thieu KP, Chung CW, Lankaraman KM, Tebas P, Silvestri G, Weiner DB.

J Virol. 2008 Dec;82(23):11536-44. doi: 10.1128/JVI.00485-08. Epub 2008 Sep 17.

2.

Phenotype and function of human T lymphocyte subsets: consensus and issues.

Appay V, van Lier RA, Sallusto F, Roederer M.

Cytometry A. 2008 Nov;73(11):975-83. doi: 10.1002/cyto.a.20643. Review.

3.

Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover.

Almeida JR, Price DA, Papagno L, Arkoub ZA, Sauce D, Bornstein E, Asher TE, Samri A, Schnuriger A, Theodorou I, Costagliola D, Rouzioux C, Agut H, Marcelin AG, Douek D, Autran B, Appay V.

J Exp Med. 2007 Oct 1;204(10):2473-85. Epub 2007 Sep 24.

4.

Low immune activation despite high levels of pathogenic human immunodeficiency virus type 1 results in long-term asymptomatic disease.

Choudhary SK, Vrisekoop N, Jansen CA, Otto SA, Schuitemaker H, Miedema F, Camerini D.

J Virol. 2007 Aug;81(16):8838-42. Epub 2007 May 30.

5.

Fully differentiated HIV-1 specific CD8+ T effector cells are more frequently detectable in controlled than in progressive HIV-1 infection.

Addo MM, Draenert R, Rathod A, Verrill CL, Davis BT, Gandhi RT, Robbins GK, Basgoz NO, Stone DR, Cohen DE, Johnston MN, Flynn T, Wurcel AG, Rosenberg ES, Altfeld M, Walker BD.

PLoS One. 2007 Mar 28;2(3):e321.

6.

Human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T(EMRA) cells in early infection are linked to control of HIV-1 viremia and predict the subsequent viral load set point.

Northfield JW, Loo CP, Barbour JD, Spotts G, Hecht FM, Klenerman P, Nixon DF, Michaëlsson J.

J Virol. 2007 Jun;81(11):5759-65. Epub 2007 Mar 21.

7.

A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection.

Hecht FM, Wang L, Collier A, Little S, Markowitz M, Margolick J, Kilby JM, Daar E, Conway B, Holte S; AIEDRP Network..

J Infect Dis. 2006 Sep 15;194(6):725-33. Epub 2006 Aug 15.

PMID:
16941337
8.

Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction.

Trautmann L, Janbazian L, Chomont N, Said EA, Gimmig S, Bessette B, Boulassel MR, Delwart E, Sepulveda H, Balderas RS, Routy JP, Haddad EK, Sekaly RP.

Nat Med. 2006 Oct;12(10):1198-202. Epub 2006 Aug 20. Erratum in: Nat Med. 2006 Nov;12(11):1329.

PMID:
16917489
9.

IL-2 production correlates with effector cell differentiation in HIV-specific CD8+ T cells.

Nomura LE, Emu B, Hoh R, Haaland P, Deeks SG, Martin JN, McCune JM, Nixon DF, Maecker HT.

AIDS Res Ther. 2006 Jul 21;3:18.

10.
11.

Higher CD4+ T cell counts associated with low viral pol replication capacity among treatment-naive adults in early HIV-1 infection.

Barbour JD, Hecht FM, Wrin T, Segal MR, Ramstead CA, Liegler TJ, Busch MP, Petropoulos CJ, Hellmann NS, Kahn JO, Grant RM.

J Infect Dis. 2004 Jul 15;190(2):251-6. Epub 2004 Jun 18.

PMID:
15216458
12.

The size and phenotype of virus-specific T cell populations is determined by repetitive antigenic stimulation and environmental cytokines.

Gamadia LE, van Leeuwen EM, Remmerswaal EB, Yong SL, Surachno S, Wertheim-van Dillen PM, Ten Berge IJ, Van Lier RA.

J Immunol. 2004 May 15;172(10):6107-14.

13.

Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load.

Deeks SG, Kitchen CM, Liu L, Guo H, Gascon R, Narváez AB, Hunt P, Martin JN, Kahn JO, Levy J, McGrath MS, Hecht FM.

Blood. 2004 Aug 15;104(4):942-7. Epub 2004 Apr 29.

14.

Relationship between the frequency of HIV-specific CD8+ T cells and the level of CD38+CD8+ T cells in untreated HIV-infected individuals.

Chun TW, Justement JS, Sanford C, Hallahan CW, Planta MA, Loutfy M, Kottilil S, Moir S, Kovacs C, Fauci AS.

Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2464-9.

15.

Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection.

Papagno L, Spina CA, Marchant A, Salio M, Rufer N, Little S, Dong T, Chesney G, Waters A, Easterbrook P, Dunbar PR, Shepherd D, Cerundolo V, Emery V, Griffiths P, Conlon C, McMichael AJ, Richman DD, Rowland-Jones SL, Appay V.

PLoS Biol. 2004 Feb;2(2):E20. Epub 2004 Feb 17. Review.

16.

Pervasive influence of hepatitis C virus on the phenotype of antiviral CD8+ T cells.

Lucas M, Vargas-Cuero AL, Lauer GM, Barnes E, Willberg CB, Semmo N, Walker BD, Phillips R, Klenerman P.

J Immunol. 2004 Feb 1;172(3):1744-53.

17.

Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidence.

Kothe D, Byers RH, Caudill SP, Satten GA, Janssen RS, Hannon WH, Mei JV.

J Acquir Immune Defic Syndr. 2003 Aug 15;33(5):625-34.

PMID:
12902808
18.

Development of a new less-sensitive enzyme immunoassay for detection of early HIV-1 infection.

Rawal BD, Degula A, Lebedeva L, Janssen RS, Hecht FM, Sheppard HW, Busch MP.

J Acquir Immune Defic Syndr. 2003 Jul 1;33(3):349-55.

PMID:
12843746
19.

Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia.

Silvestri G, Sodora DL, Koup RA, Paiardini M, O'Neil SP, McClure HM, Staprans SI, Feinberg MB.

Immunity. 2003 Mar;18(3):441-52.

20.

Failing immune control as a result of impaired CD8+ T-cell maturation: CD27 might provide a clue.

van Baarle D, Kostense S, van Oers MH, Hamann D, Miedema F.

Trends Immunol. 2002 Dec;23(12):586-91. Review.

PMID:
12464570

Supplemental Content

Support Center